Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Bio-Techne Corp (TECH) had Revenue of $272.60M for the most recently reported fiscal quarter, ending 2023-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2023-12-31

Income Statement Financials
Revenue	$272.60M
Net Income	$27.46M
Cost of Goods Sold	$96.01M
Gross Profit	$176.59M
Operating Expenses	$234.59M
Operating Income	$38.00M
Non-Operating Income/Expense	$-4.62M
Pre-Tax Income	$33.39M
Normalized Pre-Tax Income	$33.39M
Income after Taxes	$27.46M
Income from Continuous Operations	$27.46M
Consolidated Net Income/Loss	$27.46M
Normalized Income after Taxes	$27.46M
EBIT	$38.00M
EBITDA	$65.81M
Weighted-Average Shares Outstanding (Basic)	157.53M
Weighted-Average Shares Outstanding (Diluted)	160.06M
Earnings per Share (EPS) (Basic)	$0.17
Earnings per Share (EPS) (Diluted)	$0.17
Balance Sheet Financials
Current Assets	$590.64M
Property, Plant, and Equipment	$234.20M
Long-Term Assets	$2.14B
Total Assets	$2.73B
Current Liabilities	$135.23M
Long-Term Debt	$447.00M
Long-Term Liabilities	$631.96M
Total Liabilities	$767.19M
Common Equity	$1.96B
Tangible Shareholders Equity	$432.87M
Shareholders Equity	$1.96B
Common Shares Outstanding	157.14M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$142.50M
Cash Flow from Investing Activities	$-177.78M
Cash Flow from Financial Activities	$-9.89M
Beginning Cash	$180.57M
End Cash	$130.13M
Increase/Decrease in Cash	$-50.44M
Stock-Based Compensation	$22.85M
Common Stock Dividends Paid	$-25.21M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.37
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.19
Debt to Equity Ratio	0.23
Gross Margin	64.78%
Operating Margin	13.94%
EBIT Margin	13.94%
EBITDA Margin	--
Pre-Tax Profit Margin	12.25%
Profit Margin	10.08%
Free Cash Flow	$114.04M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.53
Receiveable Turnover	1.31
Days Sales in Receivables	68.49
Return on Equity	1.40%
Return on Tangible Equity	6.34%
Return on Assets	1.01%
Return on Investments	1.14%
Book Value Per Share	$12.50
Free Cash Flow per Share	$0.71
Operating Cash Flow per Share	$0.89

Data from Zacks Investment Research, Inc.